Singapore markets closed

Invitae Corporation (0JDB.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
0.0005-0.0013 (-72.22%)
As of 02:50PM BST. Market open.
Full screen
Previous close0.0018
Open0.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0000 - 0.0000
52-week range
Volume600
Avg. volume225,013
Market cap45,629
Beta (5Y monthly)2.80
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Benzinga

    SoftBank-Backed Genetic Testing Invitae's Descent from $7B Valuation to Near-Bankruptcy

    Invitae Corporation (NYSE:NVTA), backed by SoftBank Group (OTC:SFTBY) (OTC:SFTBF), is reportedly on the brink of filing for bankruptcy in the coming weeks. The San Francisco-based medical genetics company, grappling with a substantial $1.5 billion debt burden, is enlisting the expertise of restructuring advisers from FTI Consulting and legal counsel from Kirkland & Ellis to navigate its financial challenges. Amidst this financial turmoil, Invitae is actively exploring various strategic options,

  • Zacks

    Despite Fast-paced Momentum, Invitae (NVTA) Is Still a Bargain Stock

    Invitae (NVTA) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

  • Zacks

    What Makes Invitae (NVTA) a New Buy Stock

    Invitae (NVTA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).